Charles F. Wagner

Charlie Wagner serves as a Board Member for The TJX Companies, Inc. since September 2023 and has held the position of Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals since April 2019. Previous roles include Executive Vice President of Finance and Chief Financial Officer at Ortho Clinical Diagnostics from June 2015 to March 2019, and Board Member and Audit Committee Chairperson at Good Start Genetics from April 2014 to August 2017. Charlie Wagner also contributed to Bruker Corporation as Executive Vice President of Finance and Administration and Chief Financial Officer from August 2010 to June 2015, and served on its Board of Directors and Audit Committee. Additional experience includes roles at Progress Software, Millipore Corporation, Bain & Company, and Coopers & Lybrand. Academic credentials include a Bachelor of Science in Accounting from Boston College Carroll School of Management and an MBA from Harvard Business School.